*Cancer and Population Studies Group, Queensland Institute of Medical Research, Bancroft Centre
†School of Medicine, University of Queensland
‡Envoi Pathology
##Queensland Clinical Genetics Service, Royal Childrens’ Hospital, Herston, Qld
§Centre for Molecular, Environmental, Genetic and Analytic Epidemiology, School of Population Health, The University of Melbourne, Carlton, Vic., Australia
‡‡School of Paediatrics and Child Health, University of Western Australia, Nedlands
§§Genetic Services of Western Australia, Subiaco, WA
∥∥Hereditary Cancer Clinic, Prince of Wales Hospital, Randwick
¶¶Illawarra Cancer Centre, Wollongong Hospital, Wollongong, NSW, Australia
∥Department of Internal Medicine, Division of Human Genetics, Comprehensive Cancer Center
¶Department of Pathology, Ohio State University, Columbus, OH
#Zane Cohen Centre for Digestive Diseases, Mount Sinai Hospital
**Cancer Care Ontario
††Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, ON, Canada
***New Zealand Familial Gastrointestinal Cancer Registry, Auckland City Hospital
†††Department of Gastroenterology, Middlemore Hospital, Auckland, New Zealand
Conflicts of Interest and Source of Funding: Supported by National Cancer Institute, National Institutes of Health under 1R01CA123010 (Genetics of Serrated Neoplasia) and RFA # CA-95-011 and through cooperative agreements with the Australasian Colorectal Cancer Family Registry (U01 CA097735). During this work, J.P.Y. was a Cancer Council Queensland Senior Research Fellow. C.R. is a Jass Pathology Fellow. M.A.J. is an NHMRC Senior Research Fellow, and J.L.H. is an Australian fellow of the NHMRC. For the remaining authors none were declared.
Correspondence: Christophe Rosty, MD, PhD, FRCPA, Cancer and Population Studies Group, Queensland Institute of Medical Research, Bancroft Centre, 300 Herston Rd, Herston, Qld 4006, Australia (e-mail: [email protected]).
